The Oral Mucositis Treatment Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size for oral mucositis treatment has expanded significantly in recent years. The market value is projected to increase from $1.77 billion in 2024 to $1.95 billion in 2025, implying a compound annual growth rate (CAGR) of 10.2%.
The Oral Mucositis Treatment market is projected to grow to $3.20 billion by 2029, with a compound annual growth rate (CAGR) of 13.1%.
Download Your Free Sample of the 2025 Oral Mucositis Treatment Market Report and Uncover Key Trends Now!The key drivers in the oral mucositis treatment market are:
• Rising focus on personalized medicine
• Increase in the number of cancer patients
• Escalating investments in the development of innovative drugs
• Growing healthcare expenditure in emerging markets
• Increase in regulatory approvals for novel therapies
The oral mucositis treatment market covered in this report is segmented –
1) By Treatment Type: Pharmaceutical Drugs, Laser Therapy, Cryotherapy, Oral Rinses And Mouthwashes, Other Treatment Types
2) By Route Of Administration: Oral, Intravenous, Subcutaneous, Topical, Other Routes Of Administration
3) By Indication: Chemotherapy-induced Oral Mucositis, Radiotherapy-induced Oral Mucositis, Other Indications
4) By Distribution Channel: Online Pharmacies, Retail Pharmacies, Hospital Pharmacies, Direct Sales
5) By End-User: Hospitals, Homecare Settings, Ambulatory Surgical Centers, Long-term Care Facilities
The key trends in the oral mucositis treatment market are:
• The market is moving towards the development of advanced biologics for oral mucositis treatment.
• Innovation in combination therapies for better efficacy is a notable trend.
• Non-invasive treatment options are emerging, reshaping the future of the market.
• There is a rising trend in advanced research in immunotherapy for mucositis and personalized treatment regimens.
Major players in the oral mucositis treatment market are:
• Sanofi S.A.
• Amgen Inc.
• Colgate-Palmolive Company
• Aspen Pharmacare Holdings Limited
• Swedish Orphan Biovitrum AB (Sobi)
• Sunstar Group
• Norgine B.V.
• Alliance Pharma plc
• Camurus AB
• EUSA Pharma
• Galera Therapeutics Inc.
• Enzychem Lifesciences Corporation
• CANbridge Pharmaceuticals Inc.
• Jaguar Health Inc.
• Monopar Therapeutics Inc.
• EpicentRx Inc.
• Innovation Pharmaceuticals Inc.
• Oragenics Inc.
• Soleva Pharma LLC
• Soligenix Inc.
North America was the largest region in the oral mucositis treatment market in 2024